Biotech

All Articles

OS Therapies refiles $6M IPO to money HER2 drug, preclinical ADCs

.OS Therapies will specify on the NYSE American sell substitution today by means of a $6.4 thousand ...

ALX's waning CD47 feedback rate delivers stock spiraling down

.ALX Oncology's period 2 gastric cancer cells reaction fee has actually weakened. After observing it...

Ionis axes eye condition from intendeds of Roche-partnered prospect after records dissatisfy

.One More of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed desires, cui...

Biogen's chief executive officer mentioned no dangerous handle 2023. He's ready to be vibrant

.While Biogen's pharma peers are actually seeking for late-stage properties along with little threat...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Biography has been a biotech looking for a pipe after it ditched its lead possessions over t...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually handed back rights to an early Alzheimer's condition plan to Denali Therapies, ...

Takeda water faucets new mind of US oncology organization-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings as...

Vertex, beaten by AATD again, goes down 2 assets on throw out heap

.Vertex's try to treat an uncommon genetic condition has reached another problem. The biotech tossed...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of staff

.Vir Biotechnology's second-quarter earnings file wasn't short of huge news. The business invited a ...

Galapagos pauses CAR-T tissue therapy hearing over Parkinsonism case

.Galapagos has paused registration in a test of a BCMA-directed CAR-T tissue therapy, pumping the br...